Aspen is a supplier of branded and generic pharmaceuticals in more than 150 countries across the world and of consumer and nutritional products in selected territories.
The Aspen Group has a presence in South Africa, Mexico, Venezuela, Brazil, Ireland, Germany, Kenya, Nigeria, Tanzania, Uganda, United Arab Emirates, Mauritius, Hong Kong, Philippines and Australia.
Aspen is listed on the JSE Ltd and is included in its Top 40 Index.
Aspen is a leading generics manufacturer in the Southern hemisphere and is Africa’s largest pharmaceutical manufacturer.
Aspen is South Africa's leading pharmaceutical company in the private sector (IMS).
Aspen is ranked as the ninth largest generic company in the world (EvaluatePharma World Preview - June 2012).
One in four prescriptions dispensed by pharmacists in South Africa continues to be for an Aspen product.
Aspen has 17 manufacturing facilities at 12 pharmaceutical manufacturing sites on six continents. Four of the sites are located in South Africa, four in Australia, and one in each of Kenya, Tanzania, Brazil, Mexico and Germany.
Aspen has production capabilities for a wide variety of product types including tablets,
capsules, steriles, injectables, oral contraceptives, penems, nutritional products, lyophilised vials, cytotoxics, suppositories, vials, form-filled seals, liquids, semi-solids and specialist active pharmaceutical ingredients.
Aspen has an outstanding generic pipeline. These products are developed under the direction of highly skilled scientists employed by Aspen and in collaboration with other global pharmaceutical companies and research facilities.
Aspen products are renowned for their quality, efficacy and affordability.